Does NIVOLUMAB Cause Myelopathy? 14 Reports in FDA Database

Q: Does NIVOLUMAB cause Myelopathy?

14 reports of Myelopathy have been filed with the FDA for NIVOLUMAB, representing 0.0% of all NIVOLUMAB adverse event reports.

Q: How dangerous is Myelopathy from NIVOLUMAB?

Of 14 reports, 6 (42.9%) resulted in death and 5 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Myelopathy have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.

Reports of Myelopathy with NIVOLUMAB

0.0%

of all NIVOLUMAB reports

Deaths

Hospitalizations

How Dangerous Is Myelopathy From NIVOLUMAB?

Of the 14 reports, 6 (42.9%) resulted in death, 5 (35.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.

Is Myelopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does NIVOLUMAB Cause?

Death (11,216) Malignant neoplasm progression (9,363) Off label use (5,208) Diarrhoea (4,692) Fatigue (3,709) Pyrexia (3,454) Intentional product use issue (3,297) Rash (2,816) Nausea (2,805) Decreased appetite (2,619)

What Other Drugs Cause Myelopathy?

METHOTREXATE (352) CYTARABINE (185) BUPRENORPHINE (80) RITUXIMAB (79) DEXAMETHASONE (73) VINCRISTINE (60) PREDNISOLONE (57) PREDNISONE (57) CYCLOPHOSPHAMIDE (51) NELARABINE (47)

Which NIVOLUMAB Alternatives Have Lower Myelopathy Risk?

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW NIVOLUMAB vs NIZATIDINE NIVOLUMAB vs NOMEGESTROL NIVOLUMAB vs NORDAZEPAM NIVOLUMAB vs NOREPINEPHRINE

NIVOLUMAB Full Profile All Myelopathy Reports All Drugs Causing Myelopathy NIVOLUMAB Demographics